Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.
Ma BB, Lui VW, Cheung CS, Lau CP, Ho K, Hui EP, Tsui SK, Ng MH, Cheng SH, Ng PK, Tsao SW, Chan AT.
Ma BB, et al. Among authors: ng mh, ng pk.
Invest New Drugs. 2013 Feb;31(1):30-8. doi: 10.1007/s10637-012-9828-4. Epub 2012 May 8.
Invest New Drugs. 2013.
PMID: 22565394